When it comes to CLL/SLL treatment, what’s the difference between BTK inhibitors and BCL-2 inhibitors? Understanding how these treatment approaches work and how they fit into the treatment…
BTK degrader BGB-16673 reduced tumor burden in 85% of patients from a high-risk, hard-to-treat group with relapsed / refractory CLL. Dr. Stephan Stilgenbauer from Ulm University and colleagues…
NEW YORK (Reuters Health) – Very small breast tumors that generate extensive lymph node involvement may be more biologically aggressive than larger tumors with the same degree of…
NEW YORK (Reuters Health) – Results of a meta-analysis confirm that the oral tyrosine kinase inhibitor gefitinib is effective as first-line therapy in patients with advanced non-small-cell lung…
Teresa L. Knight, MD, FACOG, Chief Medical Officer of the Women’s Health Specialists of Saint Louis, discusses HPV and cervical cancer. To learn more about the Women’s Health…
Jacob G. Robison, MD, Professor of Vascular Surgery, Medical University of South Carolina, discusses renal artery stenting and the debate around prophylactic renal artery stenting. He also discusses…
NEW YORK (Reuters Health) – In patients with ulcerative colitis (UC) and primary sclerosing cholangitis (PSC), high doses of ursodeoxycholic acid (UDCA) are associated with an increased risk…
NEW YORK (Reuters Health) – Even when small, nonfunctioning pancreatic endocrine tumors are likely to be aggressive, and should be removed when they are discovered incidentally, according to…
NEW YORK (Reuters Health) – Use of the radioprotective agent amifostine to reduce xerostomia and other side effects in cancer patients undergoing radiation therapy does not decrease survival,…
NEW YORK (Reuters health) – Among premenopausal women treated for hormone-responsive breast cancer with adjuvant anastrozole, body mass index (BMI) has a significant impact on outcomes, an Austrian…
NEW YORK (Reuters Health) – Roughly one-third of venous thromboembolism (VTE) events that occur in patients who’ve had surgery for cancer happen after they leave the hospital, with…
NEW YORK (Reuters Health) – For children and adolescents with conditions that require frequent placement of intravenous lines, administration of 50% nitrous oxide makes the process of IV…
